These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37954645)

  • 21. Efficacy of short-term multidisciplinary intensive rehabilitation in patients with different Parkinson's disease motor subtypes: a prospective pilot study with 3-month follow-up.
    Chen KK; Jin ZH; Gao L; Qi L; Zhen QX; Liu C; Wang P; Liu YH; Wang RD; Liu YJ; Fang JP; Su Y; Yan XY; Liu AX; Fang BY
    Neural Regen Res; 2021 Jul; 16(7):1336-1343. PubMed ID: 33318414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
    Lee JW; Song YS; Kim H; Ku BD; Lee WW
    PLoS One; 2021; 16(2):e0246881. PubMed ID: 33566871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease.
    Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Cedarbaum JM; Orr-Urtreger A; Mirelman A; Thaler A
    Mov Disord; 2020 Jul; 35(7):1249-1253. PubMed ID: 32353202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data.
    Jeong EH; Sunwoo MK; Lee JY; Han SK; Hyung SW; Song YS
    Front Neurol; 2022; 13():976101. PubMed ID: 36119683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Importance of Early Identification for Parkinson's Disease Patients with Postural Instability and Gait Disturbance.
    Wu Y; Yang YW; Gu SC; Zhang Y; Shi R; Wang CD; Yuan CX; Ye Q
    Comput Intell Neurosci; 2022; 2022():6701519. PubMed ID: 36438683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson's Disease.
    Yang X; Li Z; Bai L; Shen X; Wang F; Han X; Zhang R; Li Z; Zhang J; Dong M; Wang Y; Cao T; Zhao S; Chu C; Liu C; Zhu X
    Front Aging Neurosci; 2022; 14():911221. PubMed ID: 35903537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations.
    Caminiti SP; Carli G; Avenali M; Blandini F; Perani D
    Mov Disord; 2022 Jan; 37(1):106-118. PubMed ID: 34596920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks.
    Schindlbeck KA; Vo A; Nguyen N; Tang CC; Niethammer M; Dhawan V; Brandt V; Saunders-Pullman R; Bressman SB; Eidelberg D
    Cereb Cortex; 2020 May; 30(5):2867-2878. PubMed ID: 31813991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    Suzuki K; Okuma Y; Uchiyama T; Miyamoto M; Sakakibara R; Shimo Y; Hattori N; Kuwabara S; Yamamoto T; Kaji Y; Hirano S; Kadowaki T; Hirata K;
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):953-959. PubMed ID: 28847794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between
    Terashi H; Taguchi T; Ueta Y; Mitoma H; Aizawa H
    J Neurol Sci; 2021 Jul; 426():117476. PubMed ID: 33975190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.
    Bartl M; Dakna M; Schade S; Wicke T; Lang E; Ebentheuer J; Weber S; Trenkwalder C; Mollenhauer B
    J Parkinsons Dis; 2022; 12(1):437-452. PubMed ID: 34719511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson's Disease.
    Jeong EH; Sunwoo MK; Hyung SW; Han SK; Lee JY
    Parkinsons Dis; 2021; 2021():2268651. PubMed ID: 34868542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report.
    Tang Y; Wei L; Wu Z; Xu P; Mo M
    BMC Neurol; 2023 Jun; 23(1):226. PubMed ID: 37301871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study.
    Markopoulou K; Aasly J; Chung SJ; Dardiotis E; Wirdefeldt K; Premkumar AP; Schoneburg B; Kartha N; Wilk G; Wei J; Simon KC; Tideman S; Epshteyn A; Hadsell B; Garduno L; Pham A; Frigerio R; Maraganore D
    Front Neurol; 2020; 11():548. PubMed ID: 32733352
    [No Abstract]   [Full Text] [Related]  

  • 38. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.
    Yang Y; Cheon M; Kwak YT
    Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.